Eli Lilly & Co. (LLY) – ETFs
-
Biotech ETF (XBI) Outperforms, Up 3.75%
-
Wall Street ends higher on hope that partial coronavirus stimulus deal may occur
-
S&P 500, Dow finish lower in volatile trade on dour Fed forecasts
-
Wall Street ticks higher, but chip stocks tumble
-
Wall Street slips as weak economic data offsets earnings strength
-
UPDATE: Merck (MRK) Falls 5% on Market Open, Leading Drugmakers Lower
-
Merck (MRK), Pfizer (PFE) Lilly (LLY) Shares Decline Amid Biotech Weakness
-
Amazon and Netflix push Wall Street higher
-
Wall Street stumbles as bond yield climb continues
-
Wall St. ends flat as media stocks slump, healthcare gains
-
Jefferies Lifts PT on Pharmaceuticals Stocks (ABBV) (NVS) (SNY) (PFE)
-
Notable ETF Movers of the Day 10/15: (ITB) (XLV) Higher; (GDX) Lower
-
Notable ETF Movers of the Day 08/24: (XKV) Higher; (KOL) (TAN) Lower
Back to LLY Stock Lookup